Addex Therapeutics Ltd – Filings and Transcripts

NASDAQ: ADXN
Share price (8/11/26): $5.95
Market cap (8/11/26): $7.532 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

Late filing notification for annual report of foreign issuer

ended 12/31/24 FY 2024

Late filing notification for annual report of foreign issuer

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement

Updated info for already-effective prospectus

Prospectus supplement for primary offering

Ownership Filter

Lawton Vincent Michael

Teyssedou Lenaic Nathanael

Kalinichev Mikhail

Hill Raymond George

News Filter

Announces Publication of Research Highlighting Therapeutic Potential of mGlu7 Modulation in Regulating Sleep and Wakefulness

Shareholders Approve All Resolutions at Annual General Meeting

Index to Unaudited Interim Condensed Consolidated Financial Statements

Convenes Annual General Meeting 2026

Reports Full Year 2025 Financial Results and Provides Corporate Update

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Notice of effectiveness

Notice of effectiveness

Notice of effectiveness